Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of pioglitazone-azilsartan,
once daily (QD), in subjects with type 2 diabetes mellitus with poor glycemic control.